Home
Inbox
Search
View Abstract
Content
Session(s)
P361 LAMA/LABA Glycopyrrolate/Formoterol Fixed-Dose Combination, Delivered Using a Novel MDI Co-Suspension ™ Delivery Technology Reduces Risk of Clinically Important Deteriorations in COPD Versus Placebo and Monocomponent MDIs
Download
Send by Mail
View Handout
Home
Inbox
Search